Cargando…
Immune cells‐derived exosomes: A promising strategy for COVID‐19 treatment
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874742/ https://www.ncbi.nlm.nih.gov/pubmed/36712172 http://dx.doi.org/10.1002/ctd2.138 |
| _version_ | 1784877834547757056 |
|---|---|
| author | Zhang, Zichen Long, Jiangang Meng, Lingjie Yang, Zhiwei Zhang, Shengli Zhang, Lei |
| author_facet | Zhang, Zichen Long, Jiangang Meng, Lingjie Yang, Zhiwei Zhang, Shengli Zhang, Lei |
| author_sort | Zhang, Zichen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9874742 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98747422023-01-25 Immune cells‐derived exosomes: A promising strategy for COVID‐19 treatment Zhang, Zichen Long, Jiangang Meng, Lingjie Yang, Zhiwei Zhang, Shengli Zhang, Lei Clin Transl Discov Commentary John Wiley and Sons Inc. 2022-10-10 /pmc/articles/PMC9874742/ /pubmed/36712172 http://dx.doi.org/10.1002/ctd2.138 Text en © 2022 The Authors. Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Commentary Zhang, Zichen Long, Jiangang Meng, Lingjie Yang, Zhiwei Zhang, Shengli Zhang, Lei Immune cells‐derived exosomes: A promising strategy for COVID‐19 treatment |
| title | Immune cells‐derived exosomes: A promising strategy for COVID‐19 treatment |
| title_full | Immune cells‐derived exosomes: A promising strategy for COVID‐19 treatment |
| title_fullStr | Immune cells‐derived exosomes: A promising strategy for COVID‐19 treatment |
| title_full_unstemmed | Immune cells‐derived exosomes: A promising strategy for COVID‐19 treatment |
| title_short | Immune cells‐derived exosomes: A promising strategy for COVID‐19 treatment |
| title_sort | immune cells‐derived exosomes: a promising strategy for covid‐19 treatment |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874742/ https://www.ncbi.nlm.nih.gov/pubmed/36712172 http://dx.doi.org/10.1002/ctd2.138 |
| work_keys_str_mv | AT zhangzichen immunecellsderivedexosomesapromisingstrategyforcovid19treatment AT longjiangang immunecellsderivedexosomesapromisingstrategyforcovid19treatment AT menglingjie immunecellsderivedexosomesapromisingstrategyforcovid19treatment AT yangzhiwei immunecellsderivedexosomesapromisingstrategyforcovid19treatment AT zhangshengli immunecellsderivedexosomesapromisingstrategyforcovid19treatment AT zhanglei immunecellsderivedexosomesapromisingstrategyforcovid19treatment |